相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure of the neurotensin receptor 1 in complex with β-arrestin 1
Weijiao Huang et al.
NATURE (2020)
Structure of the M2 muscarinic receptor-β-arrestin complex in a lipid nanodisc
Dean P. Staus et al.
NATURE (2020)
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform
Lakshmi Vasudevan et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Alexander Gillis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
A Biased View of μ-Opioid Receptors?
Alexandra E. Conibear et al.
MOLECULAR PHARMACOLOGY (2019)
Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs
Scott A. Hollingsworth et al.
NATURE COMMUNICATIONS (2019)
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy et al.
NATURE CHEMICAL BIOLOGY (2018)
GPCRdb in 2018: adding GPCR structure models and ligands
Gaspar Pandy-Szekeres et al.
NUCLEIC ACIDS RESEARCH (2018)
The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Structure of the μ-opioid receptor-Gi protein complex
Antoine Koehl et al.
NATURE (2018)
The Role of Science in Addressing the Opioid Crisis
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Understanding the GPCR biased signaling through G protein and arrestin complex structures
X. Edward Zhou et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid et al.
CELL (2017)
Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased opioid receptor agonists
David Winpenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators
Andrew C. Kruegel et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
A randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain
Eugene R. Viscusi et al.
PAIN (2016)
Recent updates on GPCR biased agonism
Andre S. Pupo et al.
PHARMACOLOGICAL RESEARCH (2016)
The role of kinetic context in apparent biased agonism at GPCRs
Carmen Klein Herenbrink et al.
NATURE COMMUNICATIONS (2016)
Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning
Chad W. Hopkins et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Recent developments in biased agonism
James W. Wisler et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
David G. Soergel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti et al.
NATURE (2014)
Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers
David G. Soergel et al.
PAIN (2014)
Emerging structural insights into biased GPCR signaling
Arun K. Shukla et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
The Dynamic Process of β2-Adrenergic Receptor Activation
Rie Nygaard et al.
CELL (2013)
Molecular dynamics simulations and statistical coupling analysis reveal functional coevolution network of oncogenic mutations in the CDKN2A-CDK6 complex
Jingwen Wang et al.
FEBS LETTERS (2013)
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data
Daniel R. Roe et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
Romelia Salomon-Ferrer et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Structure Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]a2[(9R)-9-(pyridin-2-y1)-6-oxaspiro-[4.5]clecan-9-yl]ethylpamine (TRV130), for the Treatment of Acute Severe Pain
Xiao-Tao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Co-Expression of GRK2 Reveals a Novel Conformational State of the μ-Opioid Receptor
Sarah A. Nickolls et al.
PLOS ONE (2013)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Inclusion of Many-Body Effects in the Additive CHARMM Protein CMAP Potential Results in Enhanced Cooperativity of α-Helix and β-Hairpin Formation
Robert B. Best et al.
BIOPHYSICAL JOURNAL (2012)
Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression
Merel Boom et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology
Kenneth Lamb et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges
K. Vanommeslaeghe et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing
K. Vanommeslaeghe et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone φ, ψ and Side-Chain χ1 and χ2 Dihedral Angles
Robert B. Best et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Structure of the δ-opioid receptor bound to naltrindole
Sebastien Granier et al.
NATURE (2012)
Structure of the human κ-opioid receptor in complex with JDTic
Huixian Wu et al.
NATURE (2012)
Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
Aashish Manglik et al.
NATURE (2012)
Crystal structure of the β2 adrenergic receptor-Gs protein complex
Soren G. F. Rasmussen et al.
NATURE (2011)
Activation mechanism of the β2-adrenergic receptor
Ron O. Dror et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types
Jeffery B. Klauda et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2010)
An opioid agonist that does not induce μ-opioid receptor -: Arrestin interactions or receptor internalization
C. E. Groer et al.
MOLECULAR PHARMACOLOGY (2007)
OPM: Orientations of proteins in membranes database
MA Lomize et al.
BIOINFORMATICS (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor
SK Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
LM Bohn et al.
NATURE (2000)
分享论文
